ADENOSINE THERAPEUTICS, LLC

Company Information

Company Name
ADENOSINE THERAPEUTICS, LLC
Address
310 FOURTH STREET NE
SUITE 201
CHARLOTTESVILLE, VA, 22902
Phone
n/a
URL
n/a
DUNS
1016760
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,579,257.00
9
SBIR Phase II
$4,908,100.00
5
STTR Phase I
$2,432,035.00
11
STTR Phase II
$2,191,130.00
2
Chart code to be here

Award List

  1. N/A

    Amount: $100,000.00

    N/A

    STTR Phase I 2000 Department of Health and Human Services
  2. N/A

    Amount: $100,000.00

    N/A

    STTR Phase I 2000 Department of Health and Human Services
  3. N/A

    Amount: $100,000.00

    N/A

    STTR Phase I 2000 Department of Health and Human Services
  4. N/A

    Amount: $100,000.00

    N/A

    STTR Phase I 2000 Department of Health and Human Services
  5. Novel A2A Adenosine Agonists in Vascular Protection

    Amount: $1,247,577.00

    DESCRIPTION (provided by applicant): This is a phase II SBIR proposal to develop a new drug eluting stent to prevent restenosis. It is a 3-way collaboration between Adenosine Therapeutics, LLC, Setago ...

    STTR Phase II 2004 Department of Health and Human Services
  6. Antagonists of A2B Receptors Improve Insulin Sensitivity

    Amount: $100,000.00

    DESCRIPTION (Scanned from the Applicant's Abstract): Blockade of A2B adenosine receptors (A2BARs) increases insulin sensitivity in insulin resistant obese Zucker rats by an effect on sk ...

    SBIR Phase I 2001 Department of Health and Human Services
  7. Antagonists of A2B Receptors Improve Insulin Sensitivity

    Amount: $1,424,445.00

    DESCRIPTION (provided by applicant): This is a phase II SBIR grant to develop a new therapy for the treatment of type II diabetes. Adenosine Therapeutics, LLC (ATL) is a biotechnology company started ...

    SBIR Phase II 2004 Department of Health and Human Services
  8. ANTAGONIST OF A2B ADENOSINE RECEPTORS FOR ASTHMA

    Amount: $100,000.00

    DESCRIPTION: (Adapted from the Investigator's Abstract): Adenosine administered as an aerosol to asthmatics causes bronchoconstriction, while in non-asthmatics adenosine causes bronchodilati ...

    SBIR Phase I 2001 Department of Health and Human Services
  9. Antagonists of A2B Adenosine Receptors for Asthma

    Amount: $1,440,613.00

    DESCRIPTION (provided by applicant): This is a Phase II SBIR proposal to develop a new therapy for the treatment of asthma. The desired outcome will be the identification of a therapeutic candidate to ...

    SBIR Phase II 2006 Department of Health and Human Services
  10. NOVEL ADENOSINE A2A AGONISTS IN RENAL TISSUE PROTECTION

    Amount: $0.00

    DESCRIPTION (provided by applicant): The development of new treatments for the effective reduction of renal injury associated with acute renal failure and kidney transplantation will have a great impa ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government